Islam Saqib's Form 4 filing
SpringWorks Therapeutics, Inc.SWTX · filed Jun 5, 2024
- Accession no.
- 0001104659-24-068675
- Filed
- Jun 5, 2024
- Trade date
- Jun 3, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions. Open-market sales total $1.96M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Islam SaqibCIK 0001575408 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2024 | Common Stock | SSaleDisposed | −33,240 | $39.40F2 | −$1,309,656 | 1,128,128 | Direct | |
| Jun 3, 2024 | Common Stock | SSaleDisposed | −8,760 | $40.57F3 | −$355,393.2 | 1,119,368 | Direct | |
| Jun 3, 2024 | Common Stock | SSaleDisposed | −6,600 | $41.40F4 | −$273,240 | 1,112,768 | Direct | |
| Jun 3, 2024 | Common Stock | SSaleDisposed | −400 | $42.09F5 | −$16,836 | 1,112,368 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.02 to $40.0147. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.02 to $41.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.0332 to $42.02. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.09 to $42.10. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
Remarks
On December 1, 2023, a Form 4 was filed on behalf of the Reporting Person that mistakenly underreported ownership by 905,104 shares, which discrepancy was carried forward to the Form 4 filed on January 8, 2024. No reportable transaction was omitted from such Form 4 filing. This remark serves to reconcile the inconsistency in the total amount reported under Colum 5 of Table I between (i) the Form 4s filed on December 1, 2023 and January 8, 2024 and (ii) this Form 4 filed on June 5, 2024.